Sana Khan
Reproductive Endocrinology · Oklahoma City, OKNPI 1760617146
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 28.5% of the total. Reporting peaked in 2021 at $419 and has fallen 84.5% since, to $65 in 2025.
Across 73 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$359
- Ferring Pharmaceuticals Inc.$245
- Pfizer$70
- Sage Therapeutics, LLC$58
- Mayne Pharma Commercial LLC$56
- Therapeuticsmd, Inc.$55
- plus $417 from 16 others
What the payments were for
- Food & beverage$1,258100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $359 |
| Ferring Pharmaceuticals Inc. | 15 | $245 |
| Pfizer | 4 | $70 |
| Sage Therapeutics, LLC | 3 | $58 |
| Mayne Pharma Commercial LLC | 3 | $56 |
| Therapeuticsmd, Inc. | 3 | $55 |
| Bayer | 3 | $50 |
| Evofem Biosciences, Inc. | 3 | $48 |
| Agile Therapeutics, Inc. | 2 | $35 |
| Exeltis, USA Inc. | 2 | $31 |
| Myovant Sciences Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Meditrina | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Merck | 1 | $24 |
| EMD Serono, Inc. | 1 | $24 |
| Axonics, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Convatec Inc. | 1 | $13 |
| Millicent US Inc | 1 | $12 |
How this compares
Too few reproductive endocrinology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Other reproductive endocrinology in Oklahoma City
- Latasha CraigOklahoma City$17K
- Sarah GavriziOklahoma City$8K
- Robert WildOklahoma City$3K
- Amanda FerraroOklahoma City$1K
- Karl HansenOklahoma City$664
- Sushila AryaOklahoma City$638
- Anna ReynoldsOklahoma City$567
- Stanley ProughTulsa$28K
- Shauna McKinneyTulsa$1K
- John BundrenTulsa$527
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.